Fundraising FoxKintsugitx
Barcelona, ES · 2 known investors
Find your way into Kintsugitx
Sign up to see every warm intro you have to Kintsugitx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kintsugitx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kintsugi Therapeutics is a preclinical-stage biopharmaceutical company developing first-in-class endoplasmic reticulum stress inhibitors for treating non-alcoholic steatohepatitis and other liver conditions.
Founders & leadership
CH
Carmen HerreroCo-founder & CEO
MC
Marc CusachsCo-founder & COO
Investors · 2
Frequently asked questions
- What does Kintsugitx do?
- Kintsugi Therapeutics is a preclinical-stage biopharmaceutical company developing first-in-class endoplasmic reticulum stress inhibitors for treating non-alcoholic steatohepatitis and other liver conditions.
- Who founded Kintsugitx?
- Kintsugitx was founded by Carmen Herrero, Marc Cusachs.
- Who are Kintsugitx's investors?
- Kintsugitx's investors include Capital Cell, WA4STEAM.
- Where is Kintsugitx headquartered?
- Kintsugitx is headquartered in Barcelona, ES.